Associations of Hypertriglyceridemia Onset Age With Cardiovascular Disease and All‐Cause Mortality in Adults: A Cohort Study

Hui Zhou,Xiong Ding,Qing Yang,Shuohua Chen,Yun Li,Xin Zhou,Shouling Wu

DOI: https://doi.org/10.1161/JAHA.122.026632

2022-10-18

Abstract:Background Limited studies have involved new‐onset hypertriglyceridemia, and this study was to evaluate the associations of hypertriglyceridemia onset age with cardiovascular diseases (CVD) and all‐cause mortality. Methods and Results This population‐based prospective study enrolled 98 779 participants free of hypertriglyceridemia and CVD at baseline in the Kailuan study initiated in June 2006. All participants underwent health checkups biennially until December 2017, and a total of 13 832 participants developed new hypertriglyceridemia. A 1:1 age‐ (±1 year) and sex‐matched analysis was applied to select control subject of the same year for each new‐onset case. There were 13 056 case‐control pairs included. The total follow‐up time was 179 409 person‐years, with a median follow‐up time of 7.0 years. Primary outcomes were CVD and all‐cause mortality, and hazard ratios were estimated after adjustment for baseline characteristics. A total of 807 incident CVD events and 600 all‐cause mortality events were documented. After multivariable adjustment, participants with hypertriglyceridemia onset age <45 years had the highest risk compared with matched controls, with hazard ratios of 2.61 (95% CI, 1.59–4.27) for CVD, 4.69 (95% CI, 2.34–9.40) for all‐cause mortality, 2.23 (95% CI, 0.67–7.38) for myocardial infarction, and 2.68 (95% CI, 1.56–4.62) for stroke. The risk estimates gradually decreased with each decade increase in the onset age of hypertriglyceridemia. Conclusions Among Chinese adults, hypertriglyceridemia identified at an earlier onset age was associated with higher risks for CVD and all‐cause mortality. Clinical Perspective What Is New? New‐onset hypertriglyceridemia was associated with increased risks for incident cardiovascular diseases (CVD) and all‐cause mortality independent of traditional risk factors. Hypertriglyceridemia identified at an earlier onset age was associated with higher risks for CVD and all‐cause mortality. The new‐onset hypertriglyceridemia–related CVD risk was mainly driven by an increase in stroke incidence among Chinese adults. What Are the Clinical Implications? Hypertriglyceridemia onset age was a vital determinant of CVD and all‐cause mortality. Association in younger onset, although strong, earlier identification and prevention targeting hypertriglyceridemia would favorably influence CVD and all‐cause mortality. Cardiovascular disease (CVD) remains the leading cause of mortality in adults worldwide, 1 and lipid metabolism disorders are significant risk factors for the development of CVD and all‐cause mortality. 2 The onset trend for lipid metabolism disorders at a progressively younger age 3 , 4 is consistent with increasing incidence among young individuals with CVD. 5 , 6 Furthermore, lowering low‐density lipoprotein cholesterol (LDL‐C) levels in the middle‐aged and older population is associated with a marked reduction in CVD and mortality risk. 6 , 7 Previous studies have demonstrated that residual cardiovascular risk persists even though LDL‐C is reduced to the recommended target, and this residual risk may be attributed to atherosclerotic dyslipidemia, including elevated triglycerides. 8 Although Criqui et al 9 and Angelantonio et al 10 reported no independent association between plasma triglyceride levels and CVD and mortality, emerging studies have documented a positive relationship between elevated triglycerides and increased risk of CVD and mortality, 11 , 12 , 13 and the American Heart Association has embraced the view. 8 The effect of risk factors on adverse events depends not only on the amount but also on the duration of exposure. Studies have noted that the association between risk factors and the development of diseases is age‐dependent, and the risk of CVD related to new‐onset hypertension or diabetes generally declines with onset aging. 14 , 15 However, neither the Copenhagen City Heart Study 11 , 12 , 13 nor the LRCFS 9 and ERFC Study 10 could determine the association between the age of onset of elevated triglycerides and incident CVD and mortality, which may lead to bias in risk estimates, causing an incons -Abstract Truncated-